Alejandro C. Arroliga

Alejandro C. Arroliga

Auto-generated profile, based on publicly available information

Alejandro C. Arroliga

Chief Academic Officer and Innovation Officer, Baylor Scott and White Health, and Professor of Medicine, Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2018 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
CHChristopher Henry
Christopher Henry
MZManaf Zaizafoun
Manaf Zaizafoun
ESEileen Stock
Eileen Stock
SGShekhar Ghamande
Shekhar Ghamande
AAAlejandro C. Arroliga
Alejandro C. Arroliga
HWHeath D. White
Heath D. White
Angiotensin-converting enzyme (ACE) inhibitors and statins may potentially benefit patients with viral infections and pneumonia. Our study aimed to evaluate the impact of ACE inhibitors and statins on the rates of intubation and death in viral pneumonia. We retrospectively studied 1055 adult patients admitted to a tertiary care center in central Texas with a positive respiratory viral polymerase chain reaction test. Of these, 539 had clinical presentation and imaging consistent with pneumonia. We collected information on demographic characteristics, microbiology, comorbid conditions, medication use, and outcomes. ACE inhibitors given prior to admission were associated with an increased risk of death or intubation (odds ratio [OR] = 3.02; 95% confidence interval [CI], 1.30–7.01), whereas statin use prior to admission did not change rates of death or intubation. Lower rates of death and intubation were noted with continued use of ACE inhibitors (OR =0.25; 95% CI, 0.09–0.64) and statins (OR =0.26; 95% CI, 0.08–0.81) throughout the hospital stay. We added further evidence of the beneficial effect of continued use of ACE inhibitors and statins in viral pneumonia.

14 May 2018 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
BWBobbie Ann A. White
Bobbie Ann A. White
AEAngela Eklund
Angela Eklund
TMTresa McNeal
Tresa McNeal
AHAngie Hochhalter
Angie Hochhalter
AAAlejandro C. Arroliga
Alejandro C. Arroliga
Most teams in hospital medicine are ad hoc, meaning that the teams vary in participants. Ad hoc teams can be found in academic teaching hospitals where team members change across shifts and rotations. Due to varying team membership, these teams face significant hurdles, because they lack an opportunity to develop a team identity, shared mental models, and trust. This article discusses facilitators and barriers to effective functioning of ad hoc teams. Communication, conflict management, power, and leadership are areas that either serve as facilitators or barriers to positive team function. In addition to discussing these aspects, solutions and recommendations from practice are shared. Solutions include data about successful teams, communication in those teams, and data about how to improve education and team training. These practical applications can be applied in practice to improve team functioning. Finally, we recommend that additional research be conducted in the area of ad hoc teams, because this type of team is a large part of medicine with a gap in evidence.

27 March 2017 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
AHAdam J. Hayek
Adam J. Hayek
HWHeath D. White
Heath D. White
SGShekhar Ghamande
Shekhar Ghamande
CSChristopher Spradley
Christopher Spradley
AAAlejandro C. Arroliga
Alejandro C. Arroliga
Introduction: Severe acute respiratory distress syndrome (ARDS) has a high mortality, and there is limited knowledge about management of severe ARDS refractory to standard therapy. Early evidence suggests that therapeutic hypothermia (TH) could be a viable treatment for acute respiratory failure. We present 2 cases where TH was successfully used to manage refractory ARDS on extracorporeal membrane oxygenation (ECMO) and a review of the literature around TH and acute respiratory failure. Results: We present 2 cases of ARDS secondary to H1N1 influenza and human metapneumovirus. Both patients were treated with the current evidence-based therapy for ARDS. Venovenous ECMO was used in both patients for refractory hypoxemia. Therapeutic hypothermia was applied for 24 hours with improved oxygenation. We did a review of the literature summarizing 38 patients in 10 publications where TH was successfully utilized in the treatment of acute respiratory failure. Conclusion: Therapeutic hypothermia may be a viable salvage therapy for ARDS refractory to the current evidence-based therapy but needs further evaluation.

1 May 2015 in American Journal of Infection Control
Verified
Journal Article
Closed access
JMJohn K. Midturi
John K. Midturi
ANAarthi Narasimhan
Aarthi Narasimhan
TBTeresa Barnett
Teresa Barnett
JSJamie Sodek
Jamie Sodek
WSWilliam Schreier
William Schreier
AAAlejandro C. Arroliga
Alejandro C. Arroliga

9 May 2018 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
HWHeath D. White
Heath D. White
AVAlfredo Vazquez-Sandoval
Alfredo Vazquez-Sandoval
PQPedro F. Quiroga
Pedro F. Quiroga
JSJuhee Song
Juhee Song
SJShirley F. Jones
Shirley F. Jones
AAAlejandro C. Arroliga
Alejandro C. Arroliga
Acid-base status is frequently assessed in severe sepsis and septic shock. Venous blood gas sampling is proposed as a less-invasive modality but lacks evidence within this population. The objective of this study was to evaluate the correlation and agreement between arterial blood gas (ABG), peripheral venous blood gas (pVBG), and central venous blood gas (cVBG) in severe sepsis and septic shock. We conducted a prospective, observational cohort study in subjects admitted to the medical intensive care unit. Simultaneous blood gas samples, including ABG, pVBG, and cVBG, were analyzed for correlation and agreement. Severity of illness scores revealed a mean (±SD) Sequential Organ Failure Assessment score of 7.9 ± 3.3, Simplified Acute Physiology II score of 49.3 ± 16.5, and a mortality rate of 11.9% in the intensive care unit and 16.4% in the hospital. We found a strong intraclass correlation (>0.85) for pH, partial pressure of carbon dioxide (pCO2), bicarbonate, and base excess for ABG/pVBG, ABG/cVBG, and pVBG/cVBG comparisons. Agreement by the Bland-Altman method was found for pH (bias ± SD, 0.03 ± 0.04, 0.03 ± 0.02, and 0.00 ± 0.03) but not for pCO2, partial pressure of oxygen, bicarbonate, base excess, and oxyhemoglobin saturation. In conclusion, adequate correlation and agreement between ABG/pVBG, ABG/cVBG, and pVBG/cVBG comparisons was found only for pH. The current level of evidence does not support the use of venous blood gas sampling in this setting.

1 February 2019 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
BWBobbie Ann Adair White
Bobbie Ann Adair White
CBChristie Bledsoe
Christie Bledsoe
RHRandy Hendricks
Randy Hendricks
AAAlejandro C. Arroliga
Alejandro C. Arroliga
Despite the collaborative nature of medicine, most medical professionals are not taught or trained to lead collaboratively. Even when leadership skills and content are incorporated into the curriculum, rarely is the content focused on relationship management and trust, both of which are imperative to collaborative and team leadership in medicine. Resonant leadership is a leadership framework centered on emotional and social intelligence. Emotional intelligence, a concept involving skills that can be taught and improved, has proven to be important in leadership. Resonant leaders, or leaders with social and emotional intelligence, develop positive relationships and environments, engaging team members to work toward a common goal through mindfulness, hope, and compassion. This article examines the current state of leadership education and development and proposes resonant leadership as a viable framework for education. A leadership framework heavy on emotional and social intelligence is ideal for the team environment of medicine, and there is literature to back up the positive outcomes of leading with this framework in a clinical setting, including reduction of burnout, building team trust, and better relationship management.